These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 20809066)

  • 1. Brain iron metabolism and its perturbation in neurological diseases.
    Crichton RR; Dexter DT; Ward RJ
    J Neural Transm (Vienna); 2011 Mar; 118(3):301-14. PubMed ID: 20809066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of iron transporters and regulators in Alzheimer's disease and Parkinson's disease: Pathophysiological insights and therapeutic prospects.
    Tian S; Wang B; Ding Y; Zhang Y; Yu P; Chang YZ; Gao G
    Biomed Pharmacother; 2024 Oct; 179():117419. PubMed ID: 39245001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired iron homeostasis in Parkinson's disease.
    Double KL; Gerlach M; Youdim MB; Riederer P
    J Neural Transm Suppl; 2000; (60):37-58. PubMed ID: 11205155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative diseases and therapeutic strategies using iron chelators.
    Ward RJ; Dexter DT; Crichton RR
    J Trace Elem Med Biol; 2015; 31():267-73. PubMed ID: 25716300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.
    Singh N; Haldar S; Tripathi AK; Horback K; Wong J; Sharma D; Beserra A; Suda S; Anbalagan C; Dev S; Mukhopadhyay CK; Singh A
    Antioxid Redox Signal; 2014 Mar; 20(8):1324-63. PubMed ID: 23815406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation.
    Baringer SL; Simpson IA; Connor JR
    J Neurochem; 2023 Jun; 165(5):625-642. PubMed ID: 37000124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
    Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
    Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration.
    Yokel RA
    J Alzheimers Dis; 2006 Nov; 10(2-3):223-53. PubMed ID: 17119290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain iron and neurological disorders.
    Qian Z; Wang Q; Pu Y
    Chin Med J (Engl); 1997 Jun; 110(6):455-8. PubMed ID: 9594247
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of iron in UPS impairment model of Parkinson's disease.
    Le W
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S158-61. PubMed ID: 24262171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroportin1 in the brain.
    Qian ZM; Li W; Guo Q
    Ageing Res Rev; 2023 Jul; 88():101961. PubMed ID: 37236369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of transferrins and iron-related proteins in brain iron transport: applications to neurological diseases.
    Campos-Escamilla C
    Adv Protein Chem Struct Biol; 2021; 123():133-162. PubMed ID: 33485481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases.
    Singh YP; Pandey A; Vishwakarma S; Modi G
    Mol Divers; 2019 May; 23(2):509-526. PubMed ID: 30293116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron in neurodegenerative disorders: being in the wrong place at the wrong time?
    Apostolakis S; Kypraiou AM
    Rev Neurosci; 2017 Nov; 28(8):893-911. PubMed ID: 28792913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinorganic Chemistry of Micronutrients Related to Alzheimer's and Parkinson's Diseases.
    Kola A; Nencioni F; Valensin D
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders.
    Bañuelos-Cabrera I; Valle-Dorado MG; Aldana BI; Orozco-Suárez SA; Rocha L
    Arch Med Res; 2014 Nov; 45(8):677-86. PubMed ID: 25446620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders.
    Mills E; Dong XP; Wang F; Xu H
    Future Med Chem; 2010 Jan; 2(1):51-64. PubMed ID: 20161623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.